This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2013-2022.
Company Filing History:
3 out of 524 
3 out of 953 
Years Active: 2013-2022
Title: Dennis Bourdette: Innovator in Neurodegenerative Disease Treatment
Introduction
Dennis Bourdette is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of neurodegenerative diseases, holding a total of 3 patents. His work focuses on innovative methods for treating conditions associated with myelination.
Latest Patents
Bourdette's latest patents include groundbreaking methods for treating subjects at risk of developing neurodegenerative diseases or conditions related to demyelination. These methods involve the administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof. This innovative approach aims to address issues of insufficient myelination and underdevelopment of the myelin sheath.
Career Highlights
Throughout his career, Dennis Bourdette has worked with esteemed organizations such as Oregon Health & Science University and the United States Government as represented by the Department of Veterans Affairs. His expertise and dedication to research have positioned him as a key figure in the medical community.
Collaborations
Bourdette has collaborated with notable colleagues, including Gail Marracci and Thomas S. Scanlan. These partnerships have further enhanced his research and contributions to the field.
Conclusion
Dennis Bourdette's innovative work in the treatment of neurodegenerative diseases showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving the lives of those affected by myelination disorders.